Abstract
Introduction
The cancer therapies market offers a high level of commercial reward to a
handful of companies including Roche, Sanofi-Aventis, AstraZeneca, Novartis
and Eli Lilly. Cancer therapy sales totaled over $38 billion in the seven
major pharmaceutical markets in 2008, growing at a CAGR of 17.4% between 2005
and 2008.
Scope of this research
- Forecast sales of the leading 20 cancer therapy brands in each of the
seven major markets over the period 2008 to 2018
- Analysis and segmentation of the total cancer therapies market at various
levels including drug class, country and brand
- Comprehensive profiles and analysis for the key brands, including approval
dates, patent expiries and all key events likely to impact sales
- Snapshot of the cancer therapies market in the rest of the world
Research and analysis highlights
Datamonitor forecasts the cancer therapies market to reach sales of $70.4
billion by 2018. Sales growth over the forecast period will slow as some of
the highest selling brands undergo patent expiry and several other brands will
approach market saturation.
Molecular targeted therapies will continue to drive most of the growth of the
cancer therapies market over the forecast period 20082018. This reflects this
class' s potential for increased uptake in existing indications, further
indication expansions, relatively low incursion from generics and the modest
impact of biosimilar market entrants.
Roche' s monoclonal antibody franchise dominated the cancer therapies market in
2008 and will continue to do so through to 2018. Avastin was the top selling
cancer therapy brand in 2008 and will remain the leading brand through to
2018. Expansion across a number of new tumor types and increasing uptake in
new territories will drive this growth.
Key reasons to purchase this research
- Quantify the performance of each of leading 20 cancer therapies in the
seven major markets over the period 2008 to 2018
- Assess the changing key opportunities and threats both for currently
marketed and pipeline cancer therapy brands
- Identify the leading brands in this market over the next 10 years and
understand the key factors driving their success
| 
View Cart
